Globant SA (GLOB) Stock News

A securities class action lawsuit has been filed against Globant S.A. for allegedly making false and misleading statements about its Latin American operations. The company disclosed significant failures on August 14, 2025, announcing a 2% headcount reduction (1,000 employees) and a $47.6 million restructuring charge, causing the stock to drop from $78.12 to $66.46 per share in a single day. Investors who purchased GLOB stock between February 15, 2024 and August 14, 2025 may be eligible to participate in the class action, with a June 23, 2026 deadline to seek lead plaintiff appointment.

A securities fraud class action lawsuit has been filed against Globant S.A., alleging that the company failed to disclose decreasing demand in Latin America, wage freezes in Argentina and Mexico, and client project cancellations between February 2024 and August 2025. Investors who suffered losses can participate as lead plaintiffs by June 23, 2026.

Rosen Law Firm is soliciting investors who purchased Globant S.A. (NYSE: GLOB) stock between February 15, 2024 and August 14, 2025 to join a securities class action lawsuit. The lawsuit alleges that Globant misrepresented the success of its $1 billion Latin American strategic pivot, while the company actually faced declining demand, client defections, project cancellations, and employee wage freezes in the region. The lead plaintiff deadline is June 23, 2026.

The Schall Law Firm is seeking investors who purchased Globant S.A. securities between February 15, 2024 and August 14, 2025 to join a class action lawsuit alleging securities fraud. The complaint claims Globant made false and misleading statements about its 'Latin American pivot' strategy, which failed due to declined demand and project cancellations, while simultaneously freezing wages in Latin American countries that impacted employee morale and client service.

The DJS Law Group has filed a class action lawsuit against Globant S.A. (NYSE: GLOB) for securities law violations under the Securities Exchange Act of 1934. The lawsuit alleges that Globant made false and misleading statements regarding its 'Latin American pivot' strategy, which failed to achieve the success the company claimed. The class period spans from February 15, 2024 to August 14, 2025, with a deadline of June 23, 2026 for shareholders to join the case.

Rosen Law Firm has filed class action lawsuits on behalf of investors in GRAIL, Inc. (NASDAQ: GRAL) who purchased stock between May 13, 2025 and February 19, 2026. The lawsuit alleges that GRAIL provided misleading statements regarding its NHS-Galleri trial results, concealing material adverse facts about the trial's ability to demonstrate cancer stage reduction. Investors who purchased during the class period may be eligible for compensation. The deadline to serve as lead plaintiff is August 4, 2026.

A class action lawsuit has been filed against Globant S.A. (GLOB) for allegedly making materially false statements about its business operations during the period from February 15, 2024 to August 14, 2025. The company failed to disclose decreasing demand in Latin America, wage freezes, and client project cancellations. The stock declined significantly following three negative announcements in February, May, and August 2025, with cumulative losses exceeding 65%. The deadline to file a lead plaintiff motion is June 23, 2026.

Rosen Law Firm is reminding investors who purchased Graphic Packaging Holding Company securities between February 4, 2025 and February 2, 2026 of the July 6, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges the company made false statements regarding inventory management issues, reduced demand, increased costs, and provided unreliable financial guidance for 2025.

Rosen Law Firm has filed a class action lawsuit against GeneDx Holdings Corp. (NASDAQ: WGS) on behalf of investors who purchased common stock between April 16, 2025 and May 4, 2026. The lawsuit alleges that GeneDx made false statements regarding the Fabric acquisition's impact on the company's financials and operational efficiencies, while concealing significant viability problems that negatively affected the business. Investors must move the court by August 3, 2026 to serve as lead plaintiff.

SINGAPORE , June 8, 2026 /PRNewswire/ -- VinFast Auto Ltd. announced its unaudited financial results for the first quarter ended March 31, 2026. In the first quarter of 2026, VinFast ("the Company") delivered 58,577 electric vehicles, representing an increase of 61% from the same period last year. International markets accounted for approximately 8% of total deliveries during the quarter. In Vietnam, VinFast's EV deliveries in the first quarter of 2026 increased by 53% year over year. The Company maintained its position as the number one OEM in the domestic automotive market since September 2024. Southeast Asia and India continue to be key growth markets for VinFast. At the end of the first quarter of 2026, VinFast ranked #1 BEV brand in the Philippines, #4 in India and #8 in Indonesia. The Company also delivered 143,136 units of e-scooters and e-bikes in the first quarter, representing an increase of 219% from the first quarter of 2025. In March alone, VinFast received more than 135,000 e-scooter orders and shipped over 93,000 e-scooters to dealers in Vietnam. VinFast currently holds the leading position in Vietnam's electric motorcycle market and, in March, expanded its share of the overall motorcycle market (including both ... Full story available on Benzinga.com

Rosen Law Firm announces a securities class action lawsuit against Regencell Bioscience Holdings Limited for allegedly making false and misleading statements regarding market manipulation vulnerabilities and regulatory risks during the period between October 28, 2024 and October 31, 2025. Investors have until June 23, 2026 to serve as lead plaintiff.

Rosen Law Firm has filed a class action lawsuit against Calix, Inc. on behalf of investors who purchased securities between January 28, 2026 and April 21, 2026. The lawsuit alleges that Calix made false and misleading statements regarding its profit margins, claiming the company benefited from advanced memory component purchases in Q1 but failed to disclose that supplies were dwindling and the company faced negative margin pressure from rising component costs. Investors who wish to serve as lead plaintiff must file by July 27, 2026.

Rosen Law Firm is encouraging investors with losses exceeding $100K in Regencell Bioscience Holdings Limited, Calix, Inc., and Wise Group plc to join securities class action lawsuits. The firm is seeking lead plaintiffs before the June 23, 2026 deadline. Regencell is accused of making false statements regarding market manipulation vulnerability and regulatory risks.

Rosen Law Firm is reminding investors who purchased Globant S.A. (NYSE: GLOB) stock between February 15, 2024 and August 14, 2025 of the June 23, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Globant misrepresented the success of its $1 billion Latin American strategic pivot, while the company actually faced declining demand, client defections, project cancellations, and employee wage freezes in the region.

Rosen Law Firm reminds Stellantis N.V. investors of the June 8, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Stellantis made false statements about its earnings growth potential and electrification strategy, claiming the company was not well-positioned for battery-powered electric vehicle growth and would need to take significant charges to adjust its priorities.

Rosen Law Firm has filed a class action lawsuit against AeroVironment, Inc. on behalf of investors who purchased securities between June 25, 2025 and March 10, 2026. The lawsuit alleges that AeroVironment made false and misleading statements by understating competition for its U.S. Space Force contracts (SCAR and SCN programs) and overstating its business prospects. Investors who wish to serve as lead plaintiff must file by July 27, 2026.

A class action lawsuit has been filed against Globant S.A. for allegedly making materially false statements about its business during February 2024 to August 2025. The company failed to disclose decreasing demand in Latin America, wage freezes, and client project cancellations. Three significant stock price declines followed earnings misses and restructuring announcements, with investors urged to file lead plaintiff motions by June 23, 2026.

Rosen Law Firm has filed class action lawsuits against AeroVironment, LKQ Corporation, and Babcock & Wilcox Enterprises on behalf of investors who purchased securities during specified periods. The AeroVironment lawsuit alleges the company made false statements regarding competition for U.S. Space Force contracts (SCAR and SCN programs), overstating business prospects. Investors who purchased during the Class Period may be eligible for compensation. The deadline to serve as lead plaintiff in the AeroVironment case is July 27, 2026.

A securities class action lawsuit has been filed against Babcock & Wilcox Enterprises, Inc. (BW) for allegedly making false and misleading statements regarding a Power Generation Contract with Applied Digital. The lawsuit claims that B&W's largest shareholder BRC Group Holdings stood on both sides of the contract and that Applied Digital did not actually need the products/services, raising questions about revenue recognition. Investors who purchased BW securities between November 5, 2025 and March 11, 2026 may be eligible for compensation. The lead plaintiff deadline is June 15, 2026.

Rosen Law Firm is notifying investors about multiple securities class action lawsuits. The primary case involves Veritone, Inc. (VERI), where the company allegedly made false statements about revenue and financial performance, maintained deficient internal controls, and will need to restate financial statements. The lead plaintiff deadline is July 20, 2026. Similar notices were issued for Phreesia, Inc. (PHR) and Stellantis N.V. (STLA).

NEW YORK , May 29, 2026 /PRNewswire/ -- AllianceBernstein Global High Income Fund, Inc. (NYSE: AWF ), a registered closed‑end investment company, today announced earnings for the fourth quarter ended March 31, 2026. Total net assets of the Fund on March 31, 2026 were $963,393,828 as compared with $985,227,126 on December 31, 2025 and $966,409,431 on March 31, 2025. On March 31, 2026, the net asset value per share was $11.17 based on 86,229,677 shares of common stock outstanding. March 31, 2026 December 31, 2025 March 31, 2025 Total Net Assets $963,393,828 Full story available on Benzinga.com

The Gross Law Firm has announced a securities class action lawsuit against Globant S.A. for allegedly making false and misleading statements about its Latin American operations. The company allegedly misrepresented the region as 'particularly beneficial' and 'stable' while facing decreasing demand, wage freezes in Argentina and Mexico, and client project cancellations. The deadline for lead plaintiff registration is June 23, 2026.

Rosen Law Firm is soliciting investors for multiple securities class action lawsuits. The primary case involves Graphic Packaging Holding Company (GPK), where investors who purchased securities between February 4, 2025 and February 2, 2026 may be eligible for compensation. The lawsuit alleges that Graphic Packaging made false statements regarding inventory management, demand, costs, and financial guidance. The lead plaintiff deadline is July 6, 2026. Additional class actions are mentioned for Upstart Holdings (UPST) and Immutep Ltd. (IMMP).

Rosen Law Firm is seeking lead plaintiffs for a securities class action lawsuit against POET Technologies Inc. (NASDAQ: POET) for allegedly making false and misleading statements regarding its tax status as a potential passive foreign investment company (PFIC), failing to disclose negative tax implications for U.S. stockholders, and a violation of non-disclosure agreements by defendant Thomas Mika. The lead plaintiff deadline is June 29, 2026.

Rosen Law Firm is reminding investors who purchased SES AI Corporation securities between January 29, 2025 and March 4, 2026 of the June 26, 2026 lead plaintiff deadline in an ongoing securities class action. The lawsuit alleges that SES AI made materially false statements regarding business prospects, overstated expected results from limited-operation deals, created artificial revenue through circular transactions, and failed to disclose material logistics constraints affecting Q4 2025 revenues and 2026 guidance.

The DJS Law Group has filed a class action lawsuit against Globant S.A. (NYSE: GLOB) for securities law violations under the Securities Exchange Act of 1934. The lawsuit alleges that Globant made false and misleading statements regarding its 'Latin American pivot' strategy, which failed to achieve the success the company claimed. The class period spans from February 15, 2024 to August 14, 2025, with a deadline of June 23, 2026 for shareholders to join the case.

The Schall Law Firm is seeking investors who purchased Globant S.A. securities between February 15, 2024 and August 14, 2025 to join a class action lawsuit alleging securities fraud. The complaint claims Globant made false and misleading statements about its 'Latin American pivot' strategy, which failed due to declined demand and project cancellations, while simultaneously freezing wages in Latin American countries that impacted employee morale and client service.

Rosen Law Firm is soliciting investors who suffered losses in Medpace Holdings, Stellantis N.V., and Blaize Holdings to join securities class action lawsuits. The Medpace case alleges the company made false statements about backlog cancellation rates and provided misleading growth projections. The lead plaintiff deadline for Medpace is June 8, 2026.

A class action lawsuit has been filed against Globant S.A. (GLOB) for allegedly making materially false statements about its business operations during the period from February 15, 2024 to August 14, 2025. The company failed to disclose decreasing demand in Latin America, wage freezes, and client project cancellations. The stock experienced significant declines following three separate announcements: a 27.8% drop in February 2025, a 23.6% drop in May 2025, and a 14.9% drop in August 2025. The deadline to file a lead plaintiff motion is June 23, 2026.

Rosen Law Firm has filed a class action lawsuit against Sportradar Group AG (NASDAQ: SRAD) on behalf of investors who purchased Class A ordinary shares between November 7, 2024 and April 21, 2026. The lawsuit alleges that Sportradar made false statements regarding its compliance practices, intentionally worked with black-market gambling operators despite claiming strict regulatory compliance, and had inadequate Know-Your-Customer (KYC) processes. The deadline to serve as lead plaintiff is July 17, 2026.